OMER Omeros Corp

Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.

$6.87  -0.45 (-6.15%)
As of 12/03/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/08/2009
Outstanding shares:  62,542,268
Average volume:  1,686,430
Market cap:   $457,809,402
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    682143102
ISIN:        US6821431029
Sedol:      B4NB858
Valuation   (See tab for details)
PE ratio:   -3.47
PB ratio:   -2.59
PS ratio:   5.06
Return on equity:   47.07%
Net income %:   -136.61%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy